Association between endothelial dysfunction and depression-like symptoms in chronic mild stress model of depression

Psychosomatic Medicine

Volumn 76, Issue 4, 2014, Pages 268-276

  Bouzinova, Elena V ^a   Norregaard, Rikke ^a   Boedtkjer, Donna M B ^b   Razgovorova, Irina A ^c   Moeller, Anaïs M J ^b   Kudryavtseva, Olga ^b   Wiborg, Ove ^a   Aalkjaer, Christian ^b   Matchkov, Vladimir V ^b  

^a AARHUS UNIVERSITY HOSPITAL   (Denmark)

^b AARHUS UNIVERSITY   (Denmark)

^c ST PETERSBURG STATE UNIVERSITY   (Russian Federation)

Author keywords

Chronic mild stress; Cyclooxygenase; Endothelium dependent hyperpolarization; Major depression; Nitric oxide; Resistance arteries

Indexed keywords

ACETYLCHOLINE; CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; ENDOTHELIAL NITRIC OXIDE SYNTHASE; INTERMEDIATE CONDUCTANCE CALCIUM ACTIVATED POTASSIUM CHANNEL; MESSENGER RNA; NITRIC OXIDE; NORADRENALIN; SMALL CONDUCTANCE CALCIUM ACTIVATED POTASSIUM CHANNEL; SUCROSE; BIOLOGICAL FACTOR; NITRIC OXIDE SYNTHASE; PROSTAGLANDIN SYNTHASE;

ANHEDONIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERY ENDOTHELIUM; ARTICLE; CHRONIC STRESS; CONTROLLED STUDY; DEPRESSION; DISEASE ASSOCIATION; ENDOTHELIAL DYSFUNCTION; ENZYME INHIBITION; HYPERPOLARIZATION; MAJOR DEPRESSION; MALE; MENTAL STRESS; MESENTERIC ARTERY; NONHUMAN; NUCLEOTIDE SEQUENCE; ORGAN PERFUSION; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; RESISTANCE BLOOD VESSEL; SUGAR INTAKE; VASCULAR RESISTANCE; VASODILATATION; ANIMAL; CHRONIC DISEASE; COPING BEHAVIOR; DISEASE MODEL; DRUG EFFECTS; METABOLISM; PATHOPHYSIOLOGY; PHYSIOLOGY; STENOSIS, OCCLUSION AND OBSTRUCTION; VASCULAR ENDOTHELIUM; WISTAR RAT;

ACETYLCHOLINE; ANHEDONIA; ANIMALS; BIOLOGICAL FACTORS; CHRONIC DISEASE; CONSTRICTION, PATHOLOGIC; DEPRESSION; DISEASE MODELS, ANIMAL; ENDOTHELIUM, VASCULAR; MALE; MESENTERIC ARTERIES; NITRIC OXIDE SYNTHASE; NOREPINEPHRINE; PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES; RATS; RATS, WISTAR; RESILIENCE, PSYCHOLOGICAL; STRESS, PSYCHOLOGICAL; SUCROSE; VASCULAR RESISTANCE; VASODILATION;

EID: 84900828659     PISSN: 00333174     EISSN: 15347796     Source Type: Journal    
DOI: 10.1097/PSY.0000000000000062     Document Type: Article

References (49)

1. Grippo AJ. Mechanisms underlying altered mood and cardiovascular dysfunction: The value of neurobiological and behavioral research with animal models. Neurosci Biobehav Rev 2009;33:171-80.
2. Joynt KE, Whellan DJ, O'Connor CM. Depression and cardiovascular disease: Mechanisms of interaction. Biol Psychiatry 2003;54:248-61.
3. Vanhoutte PM, Shimokawa H, Tang EH, Feletou M. Endothelial dysfunction and vascular disease. Acta Physiol (Oxf) 2009;196:193-222.
4. Toda N, Nakanishi-Toda M. How mental stress affects endothelial function. Pflugers Arch 2011;462:779-94.
5. Johnson AK, Grippo AJ. Sadness and broken hearts: Neurohumoral mechanisms and co-morbidity of ischemic heart disease and psychological depression. J Physiol Pharmacol 2006;57(Suppl 11):5-29.
6. Lett HS, Blumenthal JA, Babyak MA, Sherwood A, Strauman T, Robins C, Newman MF. Depression as a risk factor for coronary artery disease: Evidence, mechanisms, and treatment. Psychosom Med 2004;66:305-15.
7. Grgic I,Kaistha BP,Hoyer J,KohlerR. EndothelialCa+-ActivatedK+ channels in normal and impaired EDHF-dilator responsesVrelevance to cardiovascular pathologies and drug discovery. Br J Pharmacol 2009;157:509-26.
8. Wagner JA, Tennen H, Mansoor GA, Abbott G. History of major depressive disorder and endothelial function in postmenopausal women. Psychosom Med 2006;68:80-6.
9. Sherwood A, Hinderliter AL, Watkins LL, Waugh RA, Blumenthal JA. Impaired endothelial function in coronary heart disease patients with depressive symptomatology. J Am Coll Cardiol 2005;46:656-9.
10. Broadley AJ, Korszun A, Jones CJ, Frenneaux MP. Arterial endothelial function is impaired in treated depression. Heart 2002;88:521-3.
11. Rajagopalan S, Brook R, Rubenfire M, Pitt E, Young E, Pitt B. Abnormal brachial artery flow-mediated vasodilation in young adults with major depression. Am J Cardiol 2001;88:196-8.
12. Katz RJ. Animal model of depression: Pharmacological sensitivity of a hedonic deficit. Pharmacol Biochem Behav 1982;16:965-8.
13. Wiborg O. Chronic mild stress for modeling anhedonia. Cell Tissue Res 2013;354:155-69.
14. Grippo AJ, Moffitt JA, Johnson AK. Cardiovascular alterations and autonomic imbalance in an experimental model of depression. Am J Physiol 2002;282:R1333-41.
15. Jayatissa MN, Bisgaard C, Tingstrom A, Papp M, Wiborg O. Hippocampal cytogenesis correlates to escitalopram-mediated recovery in a chronic mild stress ratmodel of depression. Neuropsychopharmacology 2006;31:2395-404.
16. Willner P. Chronic mild stress (CMS) revisited: Consistency and behaviouralneurobiological concordance in the effects of CMS. Neuropsychobiology 2005;52:90-110.
17. Willner P. The validity of animal models of depression. Psychopharmacology (Berl) 1984;83:1-16.
18. Grippo AJ, Francis J, Beltz TG, Felder RB, Johnson AK. Neuroendocrine and cytokine profile of chronic mild stress-induced anhedonia. Physiol Behav 2005;84:697-706.
19. Garcia LS, Comim CM, Valvassori SS, Reus GZ, Stertz L, Kapczinski F, Gavioli EC, Quevedo J. Ketamine treatment reverses behavioral and physiological alterations induced by chronic mild stress in rats. Prog Neuropsychopharmacol Biol Psychiatry 2009;33:450-5.
20. Christiansen S, Bouzinova EV, Palme R, Wiborg O. Circadian activity of the hypothalamic pituitary adrenal axis is differentially affected in the rat chronic mild stress model of depression. Stress 2012;15:547-657.
21. Asnis GM, Halbreich U, Ryan ND, Rabinowicz H, Puig-Antich J, Nelson B, Novacenko H, Friedman JH. The relationship of the dexamethasone suppression test (1 mg and 2 mg) to basal plasma cortisol levels in endogenous depression. Psychoneuroendocrinology 1987;12:295-301.
22. Grippo AJ, Moffitt JA, Johnson AK. Evaluation of baroreceptor reflex function in the chronic mild stress rodent model of depression. Psychosom Med 2008;70:435-43.
23. Henningsen K, Andreasen JT, Bouzinova EV, Jayatissa MN, Jensen MS, Redrobe JP, Wiborg O. Cognitive deficits in the rat chronic mild stress model for depression: Relation to anhedonic-like responses. Behav Brain Res 2009;198:136-41.
24. Bergstrom A, Jayatissa MN, Mork A, Wiborg O. Stress sensitivity and resilience in the chronic mild stress rat model of depression; an in situ hybridization study. Brain Res 2008;1196:41-52.
25. Grippo AJ, Beltz TG, Weiss RM, Johnson AK. The effects of chronic fluoxetine treatment on chronic mild stressYinduced cardiovascular changes and anhedonia. Biol Psychiatry 2006;59:309-16.
26. Grippo AJ, Beltz TG, Johnson AK. Behavioral and cardiovascular changes in the chronic mild stress model of depression. Physiol Behav 2003;78: 703-10.
27. Bouzinova EV, Moller-Nielsen N, Boedtkjer DB, Broegger T, Wiborg O, Aalkjaer C, Matchkov VV. Chronic mild stress-induced depression-like symptoms in rats and abnormalities in catecholamine uptake in small arteries. Psychosom Med 2012;74:278-87.
28. MulvanyMJ, Baumbach GL,Aalkjaer C, Heagerty AM,KorsgaardN, Schiffrin EL, Heistad DD. Vascular remodeling. Hypertension 1996;28:505-6.
29. Isingrini E, Belzung C, Freslon JL, Machet MC, Camus V. Fluoxetine effect on aortic nitric oxide-dependent vasorelaxation in the unpredictable chronic mild stress model of depression in mice. Psychosom Med 2012;74:63-72.
30. Neves VJ, Moura MJ, Almeida BS, Costa R, Sanches A, Ferreira R, Tamascia ML, Romani EA, Novaes PD, Marcondes FK. Chronic stress, but not hypercaloric diet, impairs vascular function in rats. Stress 2012;15: 138-48.
31. Neves VJ, Moura MJ, Tamascia ML, Ferreira R, Silva NS, Costa R, Montemor PL, Narvaes EA, Bernardes CF, Novaes PD, Marcondes FK. Proatherosclerotic effects of chronic stress in male rats: Altered phenylephrine sensitivity and nitric oxide synthase activity of aorta and circulating lipids. Stress 2009;12:320-7.
32. Isingrini E, Surget A, Belzung C, Freslon JL, Frisbee J, O'Donnell J, Camus V, d'Audiffret A. Altered aortic vascular reactivity in the unpredictable chronic mild stress model of depression in mice: UCMS causes relaxation impairment to ACh. Physiol Behav 2011;103:540-6.
33. Lavoie KL, Pelletier R, Arsenault A, Dupuis J, Bacon SL. Association between clinical depression and endothelial function measured by forearm hyperemic reactivity. Psychosom Med 2010;72:20-6.
34. Shimokawa H, Yasutake H, Fujii K, Owada MK, Nakaike R, Fukumoto Y, Takayanagi T, Nagao T, Egashira K, Fujishima M, Takeshita A. The importance of the hyperpolarizing mechanism increases as the vessel size decreases in endothelium-dependent relaxations in rat mesenteric circulation. J Cardivasc Pharmacol 1996;28:703-11.
35. Mulvany MJ, Halpern W. Contractile properties of small arterial resistance vessels in spontaneously hypertensive and normotensive rats. Circ Res 1977; 41:19-26.
36. Feletou M, Huang Y, Vanhoutte PM. Endothelium-mediated control of vascular tone: COX-1 and COX-2 products. Br J Pharmacol 2011;164:894-912.
37. Iuchi T,AkaikeM,Mitsui T,OhshimaY, ShintaniY,AzumaH,Matsumoto T. Glucocorticoid excess induces superoxide production in vascular endothelial cells and elicits vascular endothelial dysfunction. Circ Res 2003;92:81-7.
38. Leonard B, Maes M. Mechanistic explanations how cell-mediated immune activation, inflammation and oxidative and nitrosative stress pathways and their sequels and concomitants play a role in the pathophysiology of unipolar depression. Neurosci Biobehav Rev 2012;36:764-85.
39. Broadley AJ, Korszun A, Abdelaal E, Moskvina V, Jones CJ, Nash GB, Ray C, Deanfield J, Frenneaux MP. Inhibition of cortisol production with metyrapone prevents mental stressYinduced endothelial dysfunction and baroreflex impairment. J Am Coll Cardiol 2005;46:344-50.
40. Broadley AJ, Korszun A, Abdelaal E, Moskvina V, Deanfield J, Jones CJ, Frenneaux MP. Metyrapone improves endothelial dysfunction in patients with treated depression. J Am Coll Cardiol 2006;48:170-5.
41. Paranthaman R, Greenstein AS, Burns AS, Cruickshank JK, Heagerty AM, Jackson A, Malik RA, Scott ML, Baldwin RC. Vascular function in older adults with depressive disorder. Biol Psychiatry 2010;68:133-9.
42. Greenstein AS, Paranthaman R, Burns A, Jackson A, Malik RA, Baldwin RC, Heagerty AM. Cerebrovascular damage in late-life depression is associated with structural and functional abnormalities of subcutaneous small arteries. Hypertension 2010;56:734-40.
43. Brondum E, Kold-Petersen H, Simonsen U, Aalkjaer C. NS309 restores EDHF-Type relaxation in mesenteric small arteries from Type 2 diabetic ZDF rats. Br J Pharmacol 2010;159:154-65.
44. Puzserova A, Csizmadiova Z, Andriantsitohaina R, Bernatova I. Vascular effects of red wine polyphenols in chronic stressYexposed Wistar-Kyoto rats. Physiol Res 2006;55:S39-47.
45. Puzserova A, Bernatova I. Chronic social stress increases nitric oxideY dependent vasorelaxation in normotensive rats. Interdiscip Toxicol 2010;3: 109-17.
46. Bernatova I, Puzserova A, Navarova J, Csizmadiova Z, Zeman M. Crowding-induced alterations in vascular system ofWistar-Kyoto rats: Role of nitric oxide. Physiol Res 2007;56:667-9.
47. Vane JR, Bakhle YS, Botting RM. Cyclooxygenases 1 and 2. Annu Rev Pharmacol Toxicol 1998;38:97-120.
48. Tsuboi K, Sugimoto Y, Ichikawa A. Prostanoid receptor subtypes. Prostaglandins Other Lipid Mediat 2002;68-69:535-56.
49. Busse R, Edwards G, Feletou M, Fleming I, Vanhoutte PM, Weston AH. EDHF: Bringing the concepts together. Trends Pharmacol Sci 2002;23:374-80.